Nancy L Cote, NP
Nurse Practitioner · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Berman Skin Institute Medical Group Inc · West Oak Dermatology Inc
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Nancy L Cote’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A6114 · Deceased
Licence status: Deceased · since 1933 · University of California San Francisco School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$2,854
Medicare paid this office $2,854 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 461 | More than 86% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 109 | More than 77% of doctors who do this |
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 73 · Under 65 0% · 85 and older 0% · Also on Medicaid 0% · Health risk score 0.65. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
The office billed $7,236, Medicare allowed $3,852 and paid $2,854; for 63 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$2,839
Pharmacies billed $2,839 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 78) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
74 generic and fewer than 11 brand-name prescriptions · $2,839 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 17 | $132 | $8 |
| Triamcinolone Acetonide | 11 | $65 | $6 |
Year by year
| 2024 | 78 | 45 | 0% (0) | None | $2,839 |
| 2023 | 16 | 14 | 0% (0) | None | $452 |
| 2022 | 12 | 11 | 0% (0) | None | $597 |
| 2021 | 19 | 14 | 0% (0) | 58% | $2,878 |
| 2020 | 83 | 59 | 0% (0) | 30% | $7,839 |
| 2019 | 98 | 59 | 0% (0) | 36% | $11,546 |
| 2018 | 113 | 61 | 0% (0) | None | $10,046 |
| 2017 | 103 | 50 | 0% (0) | 25% | $10,849 |
| 2016 | 106 | 50 | 0% (0) | 27% | $11,278 |
| 2015 | 79 | 47 | None | 33% | $8,758 |
| 2014 | 88 | 46 | 0% (0) | 30% | $6,287 |
| 2013 | 65 | 30 | 0% (0) | 35% | $2,960 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Estradiol | 27 | $1,211 | $45 |
2019: 3 drugs
| Estring | 11 | $5,547 | $504 |
| Estradiol | 31 | $1,014 | $33 |
| Adacel Tdap | 17 | $799 | $47 |
2018: 2 drugs
| Adacel Tdap | 11 | $506 | $46 |
| Estradiol | 24 | $429 | $18 |
2017: 2 drugs
| Estrace | 11 | $3,477 | $316 |
| Estradiol | 25 | $389 | $16 |
2016: 2 drugs
| Estrace | 12 | $3,422 | $285 |
| Estradiol | 29 | $675 | $23 |
2015: 2 drugs
| Estrace | 12 | $3,014 | $251 |
| Estradiol | 15 | $416 | $28 |
2014: 2 drugs
| Estrace | 12 | $2,504 | $209 |
| Estradiol | 17 | $326 | $19 |
2013: 1 drug
| Estradiol | 19 | $333 | $18 |
Money from drug and device companies
$1,109 in 2025
| 2025 | 14 | 62 | None | $1,109 |
| 2024 | 15 | 77 | None | $1,548 |
| 2023 | 6 | 10 | None | $185 |
| 2022 | 2 | 2 | None | $52 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $263 | 12 payments
|
| Abbvie | Skyrizi | $230 | 16 payments
|
| Sun Pharmaceutical Industries | Ilumya | $210 | 7 payments
|
| Arcutis Biotherapeutics | Zoryve | $146 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $46 | 2 payments
|
| Ucb | Bimzelx | $37 | 2 payments
|
See all 62 published payments
| Abbvie | Meals · 2025-09-13 | Skyrizi | $9 |
| Janssen Biotech | Meals · 2025-09-12 | Tremfya | $11 |
| Arcutis Biotherapeutics | Meals · 2025-09-06 | Zoryve | $7 |
| Sun Pharmaceutical Industries | Education · 2025-09-05 | None | $80 |
| Sun Pharmaceutical Industries | Meals · 2025-09-05 | Ilumya | $15 |
| Arcutis Biotherapeutics | Meals · 2025-09-03 | Zoryve | $10 |
| Janssen Biotech | Meals · 2025-08-20 | Tremfya | $22 |
| Arcutis Biotherapeutics | Meals · 2025-08-15 | Zoryve | $10 |
| Lnhc | Meals · 2025-08-14 | Zelsuvmi | $15 |
| Abbvie | Meals · 2025-08-07 | Skyrizi | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-08-01 | Dupixent | $17 |
| Pfizer | Meals · 2025-07-29 | Cibinqo | $27 |
| Sun Pharmaceutical Industries | Meals · 2025-07-25 | Ilumya | $15 |
| Abbvie | Meals · 2025-07-18 | Rinvoq | $15 |
| Janssen Biotech | Meals · 2025-07-16 | Tremfya | $14 |
| Janssen Biotech | Meals · 2025-07-11 | Tremfya | $26 |
| Abbvie | Meals · 2025-07-10 | Rinvoq | $22 |
| Arcutis Biotherapeutics | Meals · 2025-06-25 | Zoryve | $19 |
| Incyte | Meals · 2025-06-21 | Opzelura | $16 |
| Janssen Biotech | Education · 2025-06-17 | Tremfya | $80 |
| Abbvie | Meals · 2025-06-14 | Skyrizi | $11 |
| Abbvie | Meals · 2025-06-14 | Skyrizi | $2 |
| Sun Pharmaceutical Industries | Meals · 2025-06-13 | Ilumya | $45 |
| Novartis Pharmaceuticals | Meals · 2025-06-10 | Cosentyx | $24 |
| Sun Pharmaceutical Industries | Meals · 2025-06-04 | Winlevi | $6 |
| Ucb | Meals · 2025-05-30 | Bimzelx | $22 |
| Arcutis Biotherapeutics | Meals · 2025-05-28 | Zoryve | $6 |
| Janssen Biotech | Meals · 2025-05-20 | Tremfya | $16 |
| Abbvie | Meals · 2025-05-16 | Rinvoq | $23 |
| Janssen Biotech | Meals · 2025-05-15 | Tremfya | $24 |
| Galderma Laboratories L.P. | Meals · 2025-05-15 | Nemluvio | $19 |
| Arcutis Biotherapeutics | Meals · 2025-05-05 | Zoryve | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-05-01 | Dupixent | $14 |
| Janssen Biotech | Meals · 2025-04-23 | Tremfya | $12 |
| Janssen Biotech | Meals · 2025-04-12 | None | $16 |
| Arcutis Biotherapeutics | Meals · 2025-04-10 | Zoryve | $16 |
| Abbvie | Meals · 2025-04-09 | Skyrizi | $14 |
| Abbvie | Meals · 2025-04-04 | Rinvoq | $7 |
| Arcutis Biotherapeutics | Meals · 2025-04-03 | Zoryve | $10 |
| Abbvie | Meals · 2025-04-02 | Skyrizi | $16 |
| Ucb | Meals · 2025-03-28 | Bimzelx | $15 |
| Abbvie | Meals · 2025-03-27 | Skyrizi | $10 |
| Arcutis Biotherapeutics | Meals · 2025-03-26 | Zoryve | $23 |
| Abbvie | Meals · 2025-03-21 | Rinvoq | $30 |
| Janssen Biotech | Meals · 2025-03-13 | Tremfya | $11 |
| Amgen | Meals · 2025-03-07 | Otezla | $25 |
| Janssen Biotech | Meals · 2025-03-06 | Tremfya | $16 |
| Organon | Meals · 2025-03-05 | Vtama | $8 |
| Lilly USA | Meals · 2025-02-28 | Taltz | $22 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-02-26 | Ilumya | $15 |
| Arcutis Biotherapeutics | Meals · 2025-02-21 | Zoryve | $12 |
| Novartis Pharmaceuticals | Meals · 2025-02-13 | Cosentyx | $22 |
| Arcutis Biotherapeutics | Meals · 2025-02-11 | Zoryve | $9 |
| Abbvie | Meals · 2025-02-06 | Skyrizi | $20 |
| Incyte | Meals · 2025-01-31 | Opzelura | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-01-29 | Ilumya | $33 |
| Arcutis Biotherapeutics | Meals · 2025-01-22 | Zoryve | $8 |
| Janssen Biotech | Meals · 2025-01-16 | Tremfya | $16 |
| Abbvie | Meals · 2025-01-16 | Skyrizi | $14 |
| Abbvie | Meals · 2025-01-16 | Skyrizi | $4 |
| Arcutis Biotherapeutics | Meals · 2025-01-03 | Zoryve | $9 |
See earlier years (2024, 2023, 2022)
2024: $1,548
| Abbvie | Skyrizi | $635 | 31 payments
|
| Amgen | Otezla | $199 | 11 payments
|
| Lilly USA | Taltz | $132 | 8 payments
|
| Genzyme | Dupixent | $97 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $74 | 3 payments
|
| Janssen Biotech | Tremfya | $59 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $58 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $55 | 3 payments
|
| LEO Pharma | Adbry | $52 | 2 payments
|
| Incyte | Opzelura | $48 | 3 payments
|
| Galderma Laboratories L.P. | None | $43 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $33 | 2 payments
|
| Pfizer | Eucrisa | $27 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $19 | 1 payment
|
| Ucb | Bimzelx | $18 | 1 payment
|
2023: $185
| Incyte | Opzelura | $39 | 2 payments
|
| Janssen Biotech | Tremfya | $37 | 2 payments
|
| Abbvie | Rinvoq | $32 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $29 | 2 payments
|
| Pfizer | Litfulo | $28 | 1 payment
|
| Amgen | Otezla | $19 | 1 payment
|
2022: $52
| Kci USA | 3m Cavilon | $33 | 1 payment
|
| Merz North America | Xeomin | $19 | 1 payment
|
Professional record
- NPI
- 1568401735
- Licence
- CA 293350, CA 6114California A6114: Deceased
- Group
- Berman Skin Institute Medical Group Inc · West Oak Dermatology Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 363LW0102X (363LW0102X); Federal specialty code 363LX0001X (363LX0001X)
- Mailing address
- 8157 Shangrila Dr, Fair Oaks, CA, 95628
- NPI first listed
- 2006-06-05
- NPI last updated
- 2024-11-21
- NPI record certified
- 2024-11-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2155 Iron Point Rd, Folsom, CA, 95630